Subscription rights in Veloxis Pharmaceuticals will be admitted to trading and official listing on NASDAQ OMX Copenhagen as per 18 October 2012. As at the same date, ISIN DK0060048148 (VELO) will be traded exclusive of subscription rights.
| ISIN: | DK0060449130 |
| Name: | Veloxis Pharmaceuticals, T-ret |
| Proportion: |
8:3 Shareholders in Veloxis Pharmaceuticals will have the right to subscribe for 8 new shares per 3 existing shares |
| Trade in subscription rights (both days included): | 18 October 2012 to 31 October 2012 |
| Orderbook ID: | 90243 |
| Short name: | VELO T |
| Market Segment / no | OMX CPH Rights (subscription & bonus) / 15 |
| Tick Size /no | XCSE Equities, DKK / 7 |
| MIC Code | XCSE |
Veloxis Pharmaceuticals makes a rights issue of 1,206,779,946 new shares each bearing a face value of DKK 0.10. Subscription price is DKK 0.35 per share of DKK 0.10. Subscription period: 23 October 2012 to 5 November 2012, both days included.
Please note:
Subscription of new shares will take place in a temporary ISIN (DK0060449213) which will not be admitted to trading and official listing on NASDAQ OMX Copenhagen. The new shares from the rights issue will be traded in the existing ISIN (DK0060048148) after the registration of the new shares with the Danish Business Authority. The change is expected to be implemented on
NASDAQ OMX Copenhagen as per 15 November 2012.
For further information, please see the prospectus and announcements published by the company.
For further information, please contact: Helene Gaustad Jeppesen, Surveillance, tel. +45 33 93 33 66
